Hepatitis C Virus in the Hemodialysis Setting: A Review with Recommendations for Control

Hepatitis C virus (HCV) is the causative agent of most cases of bloodborne non-A, non-B (NANB) hepatitis in the United States and throughout the wodd (1-3). Nationally, the Centers for Disease Control and Prevention (CDC) estimates that 150,000 new infections with HCV occur each year and account for an estimated 21% of all acute viral hepatitis in the United States (CDC, unpublished data). Of particular concern are the chronic consequences that frequently occur as a result of HCV infection, potentially leading to chronic active hepatitis, cirrhosis, and liver cancer (4). Second-generation serologic assays for the detection of antibody to HCV (anti-HCV) contain recombinant proteins derived from both structural (core) and nonstructural regions of the HCV genome. These assays have detected anti-HCV in 70%-mo of patients with NANB hepatitis ( 5 , 6). Among patients with HCV infection, second generation assays detect anti-HCV in approximately W o (5). One of the major advantages of second generation assays is detection of antibody earlier in the course of infection (7): five to six weeks after onset of hepatitis in WO ofpatients compared with W64090 with earlier assays (5 ; HJ Alter, personal communication). For some patients with hepatitis C, however, semconversion may not occur for six to nine months after exposure or onset of symptoms, and a negative test early in the course of the infection does not exclude the diagnosis of hepatitis C (5). Some patients with NANB hepatitis remain persistently negative for anti-HCV but have hepatitis C; in these patients, HCV infection can only be detected with the use of research-based assays such as polymerase chain reaction (PCR) or immunofluorescence techniques ( 5 ) . Other patients with NANB hepatitis who remain persistently negative for anti-HCV may be infected with another viral hepatitis agent (non-ABCDE) or their liver idammation may be due to another cause (5 , 8, 9). For these reasons, the diagnosis of hepatitis C should

[1]  M. Alter,et al.  Risk factors for hepatitis C virus infection among health care personnel in a community hospital. , 1993, American journal of infection control.

[2]  R. Koretz,et al.  Non‐A, non‐B posttransfusion hepatitis: Comparing C and non‐C hepatitis , 1993, Hepatology.

[3]  T. Chan,et al.  Prevalence of Hepatitis C Virus Infection in Hemodialysis Patients: A Longitudinal Study Comparing the Results of RNA and Antibody Assays , 1993, Hepatology.

[4]  M. Alter,et al.  National surveillance of hemodialysis associated diseases in the United States, 1990. , 1993, ASAIO journal.

[5]  R. Miller,et al.  Lack of protective immunity against reinfection with hepatitis C virus. , 1993, Science.

[6]  M A Gerber,et al.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. , 1992, The New England journal of medicine.

[7]  M. Houghton,et al.  Storage conditions of blood samples and primer selection affect the yield of cDNA polymerase chain reaction products of hepatitis C virus , 1992, Journal of clinical microbiology.

[8]  M. Busch,et al.  Increased detection of hepatitis C virus (HCV)‐infected blood donors by a multiple‐antigen HCV enzyme immunoassay , 1992, Transfusion.

[9]  N. Ogata,et al.  Lack of protective immunity against reinfection with hepatitis C virus , 1992 .

[10]  Y. Kanno,et al.  Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. , 1992, Clinical nephrology.

[11]  S. Sandroni,et al.  Antibody to hepatitis C virus increases with time on hemodialysis. , 1992, Clinical nephrology.

[12]  Ding‐Shinn Chen,et al.  Prevalence of anti‐HCV and HCV viremia in hemodialysis patients in Taiwan , 1992, Journal of medical virology.

[13]  H. Margolis,et al.  Outbreak of hemodialysis-associated non-A, non-B hepatitis and correlation with antibody to hepatitis C virus. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  L. Mimms,et al.  Serological markers of posttransfusion hepatitis C viral infection , 1992, Journal of clinical microbiology.

[15]  B. Cooper,et al.  Seroprevalence of antibodies to hepatitis C virus in high-risk hospital personnel. , 1992 .

[16]  R. Selgas,et al.  Prevalence of Hepatitis c Antibodies (HCV) in a Dialysis Population at One Center , 1992, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[17]  S. Sato,et al.  Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff. , 1992, Hepato-gastroenterology.

[18]  G. Nemo,et al.  Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. , 1992, The New England journal of medicine.

[19]  R. Klein,et al.  Occupational risk for hepatitis C virus infection among New York City dentists , 1991, The Lancet.

[20]  S. Kashiwagi,et al.  Prevalence of antibody to hepatitis C virus in hemodialysis patients. , 1991, American journal of epidemiology.

[21]  S. Constantinescu,et al.  HCV seroprevalence in dialysis patients, their relatives and medical staff. , 1991, Revue roumaine de virologie.

[22]  Y. Liaw,et al.  Prevalence of antibodies to hepatitis C virus in the hemodialysis unit. , 1991, American journal of nephrology.

[23]  B. Kommerell,et al.  Prevalence of antibodies to hepatitis C virus in hemodialysis patients. , 1991, Nephron.

[24]  J. Hed,et al.  Antibody responses to hepatitis C virus and its modes of transmission in dialysis patients. , 1991, Nephron.

[25]  M. Bassendine,et al.  Low prevalence of antibody to hepatitis C virus in North East England , 1990, Journal of medical virology.

[26]  H. Margolis,et al.  Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. , 1990, JAMA.

[27]  J. Esteban,et al.  Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. , 1990, The New England journal of medicine.

[28]  E. Schiff,et al.  Hepatitis C infection in two urban hemodialysis units. , 1990, Kidney international.

[29]  R. Gish,et al.  The prevalence of hepatitis C virus antibodies among hemodialysis patients. , 1990, Annals of internal medicine.

[30]  K. Yamaguchi,et al.  Hepatitis C virus antibodies in haemodialysis patients , 1990, The Lancet.

[31]  R. Purcell,et al.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. , 1989, The New England journal of medicine.

[32]  H. Margolis,et al.  Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. , 1989, JAMA.

[33]  M. Buti,et al.  HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN , 1989, The Lancet.

[34]  Jules L. Dienstag,et al.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis , 1989 .

[35]  H. Alter Chronic Consequences of Non-A, Non-B Hepatitis , 1989 .

[36]  C. Arici,et al.  Outbreak of non-A, non-B hepatitis in centre haemodialysis patients: a retrospective analysis. , 1988, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[37]  D. Bradley,et al.  Posttransfusion Non-A, Non-B Hepatitis: Physicochemical Properties of Two Distinct Agents , 1983, The Journal of infectious diseases.

[38]  M. Favero,et al.  SURVIVAL OF HEPATITIS B VIRUS AFTER DRYING AND STORAGE FOR ONE WEEK , 1981, The Lancet.

[39]  M. Imai,et al.  Hepatitis B e antigen and infectivity of hepatitis B virus. , 1977, The Journal of infectious diseases.

[40]  D. Snydman,et al.  Hemodialysis-associated hepatitis: report of an epidemic with further evidence on mechanisms of transmission. , 1976, American journal of epidemiology.

[41]  M. Favero,et al.  Detection methods for study of the stability of hepatitis B antigen on surfaces. , 1974, The Journal of infectious diseases.

[42]  W. Szmuness,et al.  Hepatitis-B antigen on environmental surfaces. , 1973 .